gBETA Medtech OpenBETA – Founder Talk: Ping Yeh of StemoniX
August 2018 – StemoniX is aiming to accelerate the customization of individual cancer therapies and drug treatments for the world. We hope that our efforts will play a part in the cure of diseases like cancer and Alzheimer’s. Our open and honest culture respectfully challenges the status quo in healthcare so we can make breakthrough changes for society. Through our patented technology, we will minimize the toxicity risks to patients and maximize their life after treatment.
StemoniX® is transforming how medicine is discovered. By using skin or blood to create functioning microHearts® and microBrains®, StemoniX is making it possible to test medication on humans without that medication ever entering their bodies. This method of drug testing will speed up the search for new cures and enable the ability to test drug effectiveness on an individual person, so medicine works correctly the first time. For more information visit www.stemonix.com.
Interested in getting in touch? Send us an email email@example.com and we will be happy to get back to you.